Charlotte joined the Health Economics Research Unit (HERU) in November 2019 as a Research Assistant under the Assessment of Health Technologies theme. Currently, she is involved in the critical assessment of the economic methods used in single technology assessments as part of the evidence review group within the university. Previous projects include the conceptualisation and development of an economic model for childhood Asthma, health economic analysis alongside the RAACENO clinical trial and conducting a micro-costing analysis for the EDNA study. She graduated from the University of York in January 2020 with a distinction in MSc Health Economics; her MSc thesis investigated time preference as a mediator of the spousal correlation in smoking. This was completed within the unit during the summer of 2019. She also graduated from the University of Birmingham in June 2018 with a BSc Hons in Mathematical Economics and Statistics.
- BSc Mathematical Economics and Statistics2018 - University of Birmingham
- MSc Health Economics2020 - University of York
Page 2 of 2 Results 11 to 11 of 11
Darolutamide with androgen deprivation therapy for treating non-metastatic hormone-relapsed prostate cancerNational Institute for Health and Care Excellence (NICE)Books and Reports: Commissioned Reports